OPHTのニュース
Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours 2019/04/11 20:19:43 Seeking Alpha
Ophthotech (OPHT) Down 2.1% Since Last Earnings Report: Can It Rebound? 2019/03/28 13:30:57 Zacks Investment Research
Ophthotech (OPHT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ophthotech Corporation (OPHT) CEO Glenn Sblendorio on Q4 2018 Results - Earnings Call Transcript 2019/02/26 21:58:05 Seeking Alpha
Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours 2019/04/11 20:19:43 Seeking Alpha
Ophthotech (OPHT) Down 2.1% Since Last Earnings Report: Can It Rebound? 2019/03/28 13:30:57 Zacks Investment Research
Ophthotech (OPHT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ophthotech Corporation (OPHT) CEO Glenn Sblendorio on Q4 2018 Results - Earnings Call Transcript 2019/02/26 21:58:05 Seeking Alpha
Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours 2019/04/11 20:19:43 Seeking Alpha